Mankind Pharma Limited (NSE:MANKIND)

Market Cap	1.01T
Revenue (ttm)	129.10B
Net Income (ttm)	18.93B
Shares Out	412.76M
EPS (ttm)	46.42
PE Ratio	52.65
Forward PE	44.93
Dividend	2.00 (0.08%)
Ex-Dividend Date	Aug 8, 2025

Volume	125,525
Average Volume	297,234
Open	2,413.60
Previous Close	2,406.50
Day's Range	2,405.90 - 2,447.00
52-Week Range	2,115.10 - 3,054.80
Beta	0.26
RSI	42.38
Earnings Date	Nov 6, 2025

About Mankind Pharma

Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, gynaecology, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, respiratory diseases, etc. It also provides consumer healthcare products, such as condoms, pregnancy detection kits, oral contraceptives, antacid powders, vitamin a...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1991
• Employees: 26,978
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: MANKIND

Financial Performance

In 2024, Mankind Pharma's revenue was 122.07 billion, an increase of 18.98% compared to the previous year's 102.60 billion. Earnings were 19.91 billion, an increase of 4.08%.